You are invited to attend the Office for Diversity Inclusion and Community Partnership at Harvard Medical School’s Equity and Social Justice Lecture on the Impact of COVID-19 on Child and Adolescent Health coming up on Thursday, December 9. Please feel free to share this event with your circles. All are welcome!
–
During this COCA Call, clinicians will learn critical information about molecular approaches for clinical and public health applications to detect the influenza virus and SARS-CoV-2, the virus that causes COVID-19. Presenters from the Centers for Disease and Prevention (CDC) will review the most up to date guidance on clinical testing for influenza, including situations when influenza and SARS-CoV-2 are co-circulating in a community or other setting. In addition, presenters will provide in-depth discussion on cycle threshold (Ct) values from SARS-CoV-2 diagnostic assays and their correlation with viral load and infectiousness. Presenters will also discuss SARS-CoV-2 sequencing applications for public health.
Manish Patel, MD, MSc, Team Lead, Influenza Prevention and Control Team, Influenza Division, Centers for Disease Control and Prevention
John Barnes, PhD, Team Lead, Strain Surveillance and Emerging Variants, COVID-19 Response, Centers for Disease Control and Prevention
John T. Brooks, MD, Senior Science Advisor, COVID-19 Response, Centers for Disease Control and Prevention
Webinar Link: https://www.zoomgov.com/j/1609262149
Passcode: 274605
Dial In:
US: +1 669 254 5252
or +1 646 828 7666
or +1 669 216 1590
or +1 551 285 1373
One-tap mobile:
US: +16692545252,,1609262149#,,,,*274605# or +16468287666,,1609262149#,,,,*274605#
Webinar ID: 160 926 2149
During this time of thanksgiving, we are so grateful that the large majority of schools are fully opened for in-school experiences. As yet another step in providing a safe in-school experience for students, children ages 5 to 11 are now eligible to receive vaccinations specifically formulated for young children. With that in mind, it is the goal of NAFSCE and the U.S. Department of Ed provide parents and practitioners with the latest research and information so parents are able to make the best decision they can around vaccinating their children. This webinar is a unique opportunity for parents and family engagement practitioners to ask questions, share their ideas and concerns, and to get their questions answered.
Please join NAFSCE and the U.S. Department of Education on December 9 at 8:00pm, ET for an informational webinar following the official approval of the Pfizer-BioNTech age 5-11 vaccine. During the webinar, panelists including United States Deputy Secretary of Education Cindy Marten, along with representatives from the Centers for Disease Control and Prevention and the American Academy of Pediatrics, will join NAFSCE Executive Director, Vito Borrello for a series of presentations and constructive conversation to support parents and families as they consider the COVID-19 vaccine for their child(ren).
● How was the vaccine developed?
● How many children participated in the study for approval?
● Will my child(ren) be safe taking the vaccine?
● What are the side effects?
● Should my child(ren) get the vaccine?
● Where can I take my child to get the vaccine?
Parents are invited to submit questions about the vaccine on the registration form. Pre-submitted questions will help plan the content of the session. Time will also be reserved for live questions and answers at the end of the event.